The Utility of Conservative Treatment Modalities... (2017 study) Skip to main content
Systematic Review Bulletin of the Hospital for Joint Disease (2013) 2017

The Utility of Conservative Treatment Modalities in the Management of Osteonecrosis.

Osmani F, Thakkar S, Vigdorchik J, Bulletin of the Hospital for Joint Disease (2013), 2017

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers reviewed 16 studies on non-surgical treatments for osteonecrosis (bone tissue death from poor blood supply) of the hip and knee, including hyperbaric oxygen.

What They Found

This systematic review of 16 studies found that non-surgical treatments, including hyperbaric oxygen, were linked to improvements or slower disease progression in hip and knee osteonecrosis, mainly in early stages. The studies were found through searches of four databases from January 2001 to November 2015. Among the treatments assessed, hyperbaric oxygen, extracorporeal shockwave therapy and pulsed electromagnetic field therapy were each reported to delay and partly reverse disease progression. Bisphosphonates were linked to less pain and a lower rate of bone necrosis, and enoxaparin was linked to curbed progression. The review states that at stage III and beyond, these conservative treatments are no longer viable options.

What This Means for Canadian Patients

For people with hip or knee osteonecrosis, the abstract says stage I and II disease, before the bone surface collapses, can be approached with drug or biophysical treatments before more invasive measures such as core decompression are considered. Hyperbaric oxygen is one of the biophysical options reported to delay and partly reverse progression. The abstract does not give hyperbaric oxygen pressures or session counts, and it does not say which option works best. It notes that the best balance of cost, risk and benefit is still undetermined.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract says the best treatment in terms of cost, risk and benefit is still unknown and no standard of care exists, and it gives no details on the quality or design of the 16 included studies, so the strength of the evidence is unclear.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Systematic Review
Category Decompression Sickness
Source Pubmed
PubMed ID 28902603
Year Published 2017
Journal Bulletin of the Hospital for Joint Disease (2013)
MeSH Terms Conservative Treatment; Hip Joint; Humans; Knee Joint; Osteonecrosis

Cite This Study

Share

This study relates to Decompression Sickness. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Decompression Sickness

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology